Abstract:
A combined dot density and size modulation system uses dispersed dot halftoning in conjunction with dot size modulation to produce a halftone image in which both the density and size of the dots are modulated to control overall gray level. The dot density and size modulation system offers advantages over pure dot density modulation systems or pure dot size modulation systems because it allows an extra degree of flexibility which can be used to increase the visual quality of the halftoned pattern and/or increase the robustness of the halftoning to printer artifacts and variations. An input pixel value is used to independently produce a dot density value and a dot size value. The dot density value and dot size values may be obtained from, e.g., look up tables that have been optimized for print quality and printer stability. Dispersed dot halftoning is used to provide a halftone value for the desired pixel location using the dot density value. The dispersed dot halftoning may be, e.g., tone dependent error diffusion. The halftone value and the dot size value for the pixel location is then used to generate a modulated code, e.g., a pulse width modulated code, to the printer. The modulated code may include both the pulse width of the desired dot for the pixel location as well as the justification, e.g. left, center, or right, for the pixel location. The dot density and size modulation system is particularly useful in modern electrophotographic printing systems that allow the printed dot size to be almost continuously varied through the specification of a pulse width modulation (PWM) code.
Abstract:
A combined dot density (FM) and dot size (AM) modulation halftoning method and system produces a halftone in which both the density and size of the dots are modulated. In addition to modulating the dot size and density, the halftoning method can also explicitly control the size of dot clusters and different intensity levels.
Abstract:
What is disclosed is a novel system and method for performing a CMYK to CMYKKpRGB color transform which helps reduce engine-specific halftone artifacts in diverse printing devices capable of dot-on-dot printing. The present method lends adaptive color overlapping control to local color regions depending on the engine behaviors and imaging artifacts to be addressed. With such a transform, an added degree of flexibility is provided to a variety of halftoning algorithms to reduce engine-specific halftone artifacts. Advantageously, increased halftone image quality is effectuated for different engine behaviors in a computationally efficient manner. Various embodiments have been disclosed.
Abstract:
A microbial fuel cell for generating electricity. The microbial fuel cell includes an anode and a cathode electrically coupled to the anode. The anode is in contact with a first fluid including microorganisms capable of catalyzing the oxidation of ammonium. The anode is in contact with a second fluid including microorganisms capable of catalyzing the reduction of nitrite. The anode and the cathode may be housed in a single compartment, and the cathode may rotate with respect to the anode. The microbial fuel cell can be used to remove ammonium from wastewater, to generate electricity, or both.
Abstract:
A method to determine the color status of a scanned original segments a binary halftone image into a predetermined number of local windows and converts each local window to a device-independent color space. The method then determines a color space parameter for each local window and compares the color space parameters for the local windows to at least one threshold to determine the color status of the scanned original. An apparatus having a scanner creates a scanned image of an original and has at least one processor to create a binary halftone image from the scanned image, segment the binary halftone image into a predetermined number of local windows, convert each local window to a device-independent color space, determine a color space parameter for each local window, and compare the color space parameter for each local window to at least one threshold to determine the color status for the scanned original.
Abstract:
A method of gray component replacement receives a current pixel color value. A highlight likelihood and color neutrality is determined for the current pixel color value. An output pixel color value depending upon the color neutrality and the highlight likelihood is generated. The input pixel color value is obtained from an image acquisition system and the output color pixel value is used by an output engine to render the pixel.
Abstract:
Scanners typically capture image data in a device-dependent RGB space, after which the signal is converted to a device-independent color space. The color data capture and calibration is often not sufficiently accurate and sometimes leads to a visible color difference in hardcopy output. Methods for improving the accuracy include scanning a document into RGB image data, converting the image data of the scanned document into a first device-independent color space, applying a correction transform to modify the image data in the first device-independent color space to reduce the error in the image data, and mapping the modified coordinates to a second output color space for printing.
Abstract:
The present invention discloses a method of automatically detecting a page size for a digital scanning operation. The method includes establishing vertical and horizontal limits of an image area containing image content features of a pre-scanned image, detecting vertical page edge information of the image area, and detecting horizontal page edge information of the image area, such that the vertical and horizontal page edge information define the page size for the pre-scanned image.
Abstract:
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
Abstract:
A bioelectrochemical system includes an anode, a saline solution chamber, and a cathode. The anode is at least partially positioned within an anode chamber containing an aqueous reaction mixture including one or more organic compounds and one or more bacteria for oxidizing the organic compounds. The saline solution chamber contains a draw solution and is separated from the anode chamber by a forward osmosis membrane. Water diffuses across the forward osmosis membrane from the aqueous reaction mixture to the draw solution.